Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

604.14 -1.68 (-0.28%)
Streaming Delayed Price Updated: 12:17 PM EDT, Jul 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
2 Momentum Stocks with Exciting Potential and 1 We Question
Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such a... 
Via StockStory
News headline image
Why Is Medpace (MEDP) Stock Soaring Today
What Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) jumped 14.4% in the afternoon session after the company reported second-qua... 
Via StockStory
News headline image
Medpace Q2 Earnings Call Highlights ↗
Medpace (NASDAQ:MEDP) reported double-digit growth in second-quarter revenue and earnings, while management described the business environment as strong and said lower cancellations helped drive record... 
Via MarketBeat
Topics Earnings
The market is filled with gapping stocks in Thursday's session. ↗
Via Chartmill
Medpace Holdings (NASDAQ:MEDP) Jumps 17% After Q2 Earnings Beat and Raised Guidance ↗
Via Chartmill
Topics Earnings
Medpace Holdings Inc (NASDAQ:MEDP) Passes Key CAN SLIM Filters Amid Market Caution ↗
Via Chartmill
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
News headline image
Medpace (NASDAQ:MEDP) Exceeds Q2 CY2026 Expectations, Stock Jumps 18.6%
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 17.2% year on year ... 
Via StockStory
News headline image
What To Expect From Medpace’s (MEDP) Q2 Earnings
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting earnings this Wednesday after market hours. Here’s what investors should know. Med... 
Via StockStory
News headline image
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme... 
Via StockStory
News headline image
3 Market-Beating Stocks to Target This Week
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y... 
Via StockStory
News headline image
1 Profitable Stock to Consider Right Now and 2 We Brush Off
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
3 Cash-Producing Stocks with Promising Prospects
Businesses with strong free cash flow tend to be more adaptable and resilient. Some of these companies shine bright by using their cash wisely to strengthen ... 
Via StockStory
News headline image
2 Reasons to Watch MEDP and 1 to Stay Cautious
Shareholders of Medpace would probably like to forget the past six months even happened. The stock dropped 28.2% and now trades at $423.89. This may have inv... 
Via StockStory
News headline image
Reflecting On Drug Development Inputs & Services Stocks’ Q1 Earnings: Medpace (NASDAQ:MEDP)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a... 
Via StockStory
News headline image
The 5 Most Interesting Analyst Questions From Medpace’s Q1 Earnings Call
Medpace’s first quarter was marked by substantial year-over-year revenue growth, but management’s discussion centered on increased project cancellations and ... 
Via StockStory
Topics Earnings
News headline image
MEDP Q1 Deep Dive: Rising Cancellations and Bookings Lag Shape 2026 Outlook
Clinical research company Medpace Holdings (NASDAQ:MEDP) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 26.5% year on year to $706.6 mil... 
Via StockStory
News headline image
Medpace (MEDP) Q1 2026 Earnings Transcript ↗
Medpace (MEDP) Q1 2026 Earnings Transcript 
Via The Motley Fool
These stocks are gapping in today's session ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Medpace’s (NASDAQ:MEDP) Q1 CY2026 Sales Beat Estimates But Stock Drops 19.8%
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 26.5% year on y... 
Via StockStory
Topics Earnings
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Medpace (MEDP) Q2 2025 Earnings Transcript ↗
Medpace (MEDP) Q2 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Medpace (MEDP) Q1 Earnings: What To Expect
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting earnings this Wednesday after the bell. Here’s what to look for. Medpace beat anal... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Mid-Cap Stock for Long-Term Investors and 2 We Avoid
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
3 Market-Beating Stocks with Exciting Potential
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ... 
Via StockStory
Topics Credit Cards
News headline image
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
3 Big Reasons MEDP Should Be On Your Watchlist
Over the past six months, Medpace’s shares (currently trading at $483.21) have posted a disappointing 11.2% loss while the S&P 500 was down 5.5%. This might ... 
Via StockStory
Topics Stocks
News headline image
Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services ind... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.